ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,703Medicare Part D Prescriptions Filled, Including Refills

Rank: 202 out of 890

$699K Total Retail Price of All Prescriptions

Rank: 146 out of 890

318 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 318 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

25% of this provider’s 318 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,939 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 451 342 1 2
HYDROCODONE-ACETAMINOPHEN 325 287 S3 2 3
ZOLPIDEM TARTRATE 288 240 3 19
SIMVASTATIN 270 227 4 5
AMLODIPINE BESYLATE 236 220 5 1
PRAVASTATIN SODIUM 220 178 6 10
OMEPRAZOLE 211 196 7 8
CARVEDILOL 206 188 8 22
CRESTOR 202 171 9 25
GABAPENTIN 200 178 10 12
LISINOPRIL 197 176 11 4
FUROSEMIDE 191 174 12 7
GLIMEPIRIDE 176 158 13 27
HYDROCHLOROTHIAZIDE 165 118 14 9
SYNTHROID 159 140 15 53
NEXIUM 158 116 16 14
METFORMIN HCL 151 121 17 6
PANTOPRAZOLE SODIUM 139 116 18 34
CYMBALTA 134 109 19 45
TRAMADOL HCL 125 113 20 16
POTASSIUM CHLORIDE 124 122 21 11
VITAMIN D2 121 104 22 225
LISINOPRIL-HYDROCHLOROTHIAZIDE 118 104 23 21
CITALOPRAM HBR 118 95 23 20
ATORVASTATIN CALCIUM 115 94 25 13
CLOPIDOGREL 106 101 26 28
MELOXICAM 105 77 27 18
LOSARTAN POTASSIUM 99 86 28 29
DIOVAN 97 92 29 33
SERTRALINE HCL 92 91 30 26
FENTANYL 90 88 S2 31 151
PLAVIX 84 84 32 42
PREDNISONE 84 71 32 47
AMLODIPINE BESYLATE-BENAZEPRIL 83 83 34 41
PAROXETINE HCL 82 73 35 68
ESCITALOPRAM OXALATE 80 60 36 51
LOSARTAN-HYDROCHLOROTHIAZIDE 69 33 37 57
NAMENDA 68 64 38 36
ENALAPRIL MALEATE 68 67 38 56
WARFARIN SODIUM 67 67 40 24
DEXILANT 65 49 41 138
METANX 64 56 10 42 363
VENLAFAXINE HCL ER 63 52 43 114
CIPROFLOXACIN HCL 60 47 44 58
SEROQUEL XR 60 44 44 240
SPIRONOLACTONE 59 50 46 85
AMITRIPTYLINE HCL 58 51 R 47 43
TRICOR 57 57 48 98
DILTIAZEM ER 57 23 48 129
LYRICA 55 14 50 71
SPIRIVA 55 53 50 66
METOPROLOL SUCCINATE 53 46 52 17
CLONIDINE HCL 51 41 53 35
HYDRALAZINE HCL 51 51 53 100
ALLOPURINOL 50 42 55 31
ALENDRONATE SODIUM 50 45 55 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.